Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Fructans of Agave tequilana –A new pharmaceutical excipient?
M. L. NguyenDr. H. Rein, Dr. W. Praznik*
Pharmazeutische Technologie Rheinische Friedrich-Wilhelms-Universität Bonn
*Boku Wien
Vortrag Nr. 5.5
Index
1. General information on agavefructans2. Physico-chemical properties
2.1 X-ray diffraction2.2 Dynamic water vapour sorption2.3 Determination of adherence properties
3. Possible useability3.1 Influence on the glass transition temperature3.2 Granulation and tablet compaction
4. Conclusion5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik:
Fructans of Agave tequilana:– A new pharmaceutical excipient?
1. General information on Agavefructan
• Agave tequilana Weber, Var. azul• Watersolubale oligo- and polysaccherides• Structure is made of several fructose- and
one glucose units• Unique carbohydrate with a content of
about 17 %
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Extracton of the Agavefructans
• 6 to 8 years old plant, before flowering• Stem is ground up to pulp• Pulp is extracted with water• Resulting juice is cleaned with charcoal, evaporated to a
syrup with a concentration of 70 %• Syrup processed by spray drying
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
SEM-pictures
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Index
1. General information on agavefructans2. Physico-chemical properties
2.1 X-ray diffraction2.2 Dynamic water vapour sorption2.3 Determination of adherence properties
3. Possible useability3.1 Influence on the glass transition temperature3.2 Granulation and tablet compaction
4. Conclusion5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik:
Fructans of Agave tequilana:– A new pharmaceutical excipient?
DVS Agavenfructan vs. SorbitolDVS Isotherm Plot
0
10
20
30
40
50
60
70
80
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105
Target RH (%)
Cha
nge
InM
ass
(%)-
Dry
Cycle 1 Sorp Cycle 1 Desorp
DVS Isotherm Plot
0
10
20
30
40
50
60
70
80
90
100
110
120
0 20 40 60 80 100 120
Target RH (%)
Cha
nge
InM
ass
(%)-
Dry
Cycle 1 Sorp Cycle 1 Desorp
2.3 Adherence properties
• Agavefructan + Water ! sticky mass• Pharmaceutical useability of adhesive substances:
- TTS- Binding granulation- Bioadhesive medical formulas
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Adherence strength determination
• Adherence calculationvia texture analyzer
• Water solubleagavenfructan solutionvs. water soluble PVP-solution
• Observation of adherence strenght afterdifferent time intervals
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Force-time-diagram
Declining peak withneg. strength
Helt strength of 10 N
Interpreted peakwith pos. strength
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Maximum adherence strength results 1
• Agavenfructan-solution (30 %) 3,40 N after 75 min drying time
• PVP-solution (30 %) 2,25 N after 45 min drying time
• Adherence strength of the agavenfructan-solutionstays the same for more than 180 min
• Adherence strength of the PVP-solution only staysthe same for 60 min
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Maximum adherence strength results 2
• Storage of the sample in the conditioning cabinet of 25 °C and 60 % RH
• Adherence strength of the agavenfructan sampleremained at ca. 2 N
• No measureable adherence strength of the PVP samples
• Agavenfructan binds moistureadherence strength stays stable
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Index
1. General information on agavefructans2. Physico-chemical properties
2.1 X-ray diffraction2.2 Dynamic water vapour sorption2.3 Determination of adherence properties
3. Possible useability3.1 Influence on the glass transition temperature3.2 Granulation and tablet compaction
4. Conclusion5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik:
Fructans of Agave tequilana:– A new pharmaceutical excipient?
3.1 Influence on the glasstransition temperature
• Platisizerglass transition temperature ↓
• Production of water soluable gelatinfilms withdifferent quantities of agavefructan
• Determination of glass transition temperature via differential scanning calorimetry (DSC)
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Declining glass transitiontemperature via DSC
40
50
60
70
80
0 10 20 30 40 50 60 70 80 90 100
Fructanratio [%]
Gla
ss tr
ansi
tion
tem
pera
ture
[°C
]
Declining glass transition temperature
• Glass transition temperature delines with increasingconcentration of agavefructan
• Usable for softener• Possible usage to reduce brittelness e.g. in extrusions• Possible increase in flexibility of polymers
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
3.2 Granulation with agavefructan
• Usage as binder and filler• Sorptions- und Desorptions behaviour• Scanning electron microscope (SEM) observation• Granulation recipes
1: Fructan (20), Baldrian (20), Granulac 200 (60)2: Avicel (20), Baldrian (20), Granulac 200 (60)
(Lehmann&Voss, Hamburg)
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Dynamic water vapoursorption of the granulatesDVS Isotherm Plot
0
10
20
30
40
50
60
70
0 20 40 60 80 100 120
Target RH (%)
Cha
nge
InM
ass
(%)-
Dry
Cycle 1 Sorp Cycle 1 Desorp
DVS Isotherm Plot
0
10
20
30
40
50
60
70
80
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105
Target RH (%)
Cha
nge
InM
ass
(%)-
Dry
Cycle 1 Sorp Cycle 1 Desorp
Tablet making with agavenfructan
• Compression of the granules withpneumohydraulic tablet press (Flexitab, punch: 10 mm biplan)
• Pressure-break resistance profile of tabletscontaining agavenfructan vs. avicel
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Pressure-break resistance profile
01020304050607080
0 5 10 15 20 25 30 35
Preßkraft [kN]
Bruc
hfes
tigke
it [N
]
Tablettiermischung 1 Tablettiermischung 2
Tablettiermischung 1: Baldrian (20), Agavenfructan (20), Granulac 200 (60)Tablettiermischung 2: Baldrian (20), Avicel (20), Granulac 200 (60)
Tablet making with agavenfructan
• Good compression of the granules without bindingagents
• Stable tablets possible even under low pressure• Even tablet surface, homogenous consistency
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Surface of the fructan tablet
• plastic deformable• homogenous
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Surface of the starch tablet
• rebound afterpressure removed(elastic)
• deep cracks remain
10 % potato starch90 % Sorbitol
Agavenfructan for hydrolysis protection
• Usage in formulas with hydrolysis sensitive activeagent such as phanacetin(Expl.: Aspirin-CaCO3)
• Hygroscopic agavenfructan binds moisture out of theair
• Liberation/follow up examinations to provehydrolysis protection are still to be done
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?
Conclusion
• Usable as plastisizer• Shows good glue properties• Useable as binder in granulation• Useable as filler in tablet making• Compromised by hydroscopic properties
5.5: M. L. Nguyen, H. Rein, Dr. W. Praznik: Fructans of Agave tequilana:– A new pharmaceutical excipient?